- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased leukocyte cell number / IMPC
- increased circulating insulin level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- abnormal bone structure / IMPC
- decreased lean body mass / IMPC
- decreased circulating cholesterol level / IMPC
- abnormal humerus morphology / IMPC
- decreased circulating serum albumin level / IMPC
- increased total body fat amount / IMPC
- decreased bone mineral content / IMPC
- increased fasting circulating glucose level / IMPC
C57BL/6N-Atm1Brd Fbf1tm1a(EUCOMM)Wtsi/WtsiCnrm
Status | Available to order |
EMMA ID | EM:14358 |
Citation information | RRID:IMSR_EM:14358 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Atm1Brd Fbf1tm1a(EUCOMM)Wtsi/WtsiCnrm |
Alternative name | EPD0456_2_F09 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Fbf1tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Fbf1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0456_2_F09. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- abnormal bone structure / IMPC
- decreased circulating serum albumin level / IMPC
- increased circulating insulin level / IMPC
- increased leukocyte cell number / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased total body fat amount / IMPC
- decreased lean body mass / IMPC
- decreased circulating LDL cholesterol level / IMPC
- abnormal humerus morphology / IMPC
- decreased bone mineral content / IMPC
- increased fasting circulating glucose level / IMPC
- decreased circulating cholesterol level / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).